作者:Babatope Akinbobuyi、Lei Wang、Katherine C. Upchurch、Matthew R. Byrd、Charles A. Chang、Jeremy M. Quintana、Rachel E. Petersen、Zacharie J. Seifert、José R. Boquin、SangKon Oh、Robert R. Kane
DOI:10.1016/j.bmcl.2016.07.049
日期:2016.9
Fifteen new substituted adenines were synthesized as potential TLR7 agonists. These compounds, along with 9 previously reported compounds, were analyzed for TLR7 activity and for the selective stimulation of B cell proliferation. Several functionalized derivatives exhibit significant activity, suggesting their potential for use as vaccine adjuvants.
合成了十五种新的取代腺嘌呤作为潜在的TLR7激动剂。分析了这些化合物以及9种先前报道的化合物的TLR7活性和B细胞增殖的选择性刺激。几种功能化的衍生物表现出显着的活性,表明它们可用作疫苗佐剂的潜力。